ZMYM2 and type 2 diabetes mellitus: Results demonstrated that compared with the normal control group (NC group), CPD, GGCT, SUZ12, and ZMYM2 exhibited significantly elevated expression in both CHD and T2D model groups (P < 0.05), with consistent upregulation trends across disease models.